| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 2 |
| 1 | CLONAZEPAM | 2 |
| 2 | MISOPROSTOL | 2 |
| 3 | NICOTINE | 2 |
| 4 | NICOTINE TRANSDERMAL SYSTEM | 2 |
| 5 | OXYTOCIN | 2 |
| 6 | TEMAZEPAM | 2 |
| 7 | ATAZANAVIR | 1 |
| 8 | ATAZANAVIR SULFATE | 1 |
| 9 | CEFDINIR | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXYTOCIN | 2 | 0.0007 |
| 1 | MISOPROSTOL | 2 | 0.0002 |
| 2 | CEFDINIR | 1 | 0.0001 |
| 3 | DASPONE | 1 | 0.0001 |
| 4 | DAPSONE GEL, 5% | 1 | 0.0001 |
| 5 | DAPSONE | 1 | 0.0001 |
| 6 | ATAZANAVIR | 1 | 0.0001 |
| 7 | TEMAZEPAM | 2 | 0.0001 |
| 8 | NICOTINE | 2 | 0.0000 |
| 9 | PAROXETINE HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 2 | 0.0007 |
| 1 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 2 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Sulfone [EPC] | 1 | 0.0001 |
| 4 | Cholinergic Nicotinic Agonist [EPC] | 2 | 0.0000 |
| 5 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 3 | 0.0000 |
| 9 | Insulin Analog [EPC] | 2 | 0.0000 |